| Product Name | MF | CAS | Details |
|---|
| AChE/BChE-IN-9 | C20H19N3O4 | 2761542-55-4 | Details |
| CSF1R-IN-13 | C21H20N4O3 | 2361556-61-6 | Details |
| HSV-1/HSV-2-IN-2 | C17H14ClFN4OS | 2490468-39-6 | Details |
| AM-1488 | C19H17N3O4S | 2079895-60-4 | Details |
| ASIC-IN-1 | C23H25N3O2 | 308088-10-0 | Details |
| SARS-CoV-2-IN-17 | C19H19F3N2O3 | 2761911-44-6 | Details |
| CXCR4 antagonist 6 | C21H30N6 | 2304750-68-1 | Details |
| ATP synthase inhibitor 2 | C21H22N2O3S | 2814540-76-4 | Details |
| TGFβ-IN-2 | C22H22N2O4 | 2387678-02-4 | Details |
| A1AR antagonist 4 | C23H25N3O2 | 1031993-35-7 | Details |
| EGFR-IN-51 | C21H15N3O2S | 2418549-32-1 | Details |
| BuChE-IN-6 | C21H26N4O2 | 2003213-07-6 | Details |
| Tubulin polymerization-IN-10 | C18H21NO6S | 2238784-19-3 | Details |
| ATG7-IN-2 | C11H16N6O7S | 2226227-75-2 | Details |
| Antitumor agent-38 | C22H24N2O4 | 2744193-34-6 | Details |
| Cdc7-IN-18 | C19H21N5OS | 2562329-14-8 | Details |
| Myt1-IN-2 | C18H16N6O2S | 2719748-43-1 | Details |
| Autophagy inducer 3 | C24H43NO2 | 2691054-63-2 | Details |
| S07-2005 (racemic) | C20H23NO6 | 1826337-40-9 | Details |
| Antitubercular agent-24 | C18H19N3O2S2 | 1845719-43-8 | Details |
| ANO1-IN-2 | C16H14ClN3O2S2 | 637314-12-6 | Details |
| NMDA receptor antagonist 5 | C19H16BrNO2 | 2415998-36-4 | Details |
| Tyrosinase-IN-5 | C18H13N3O6 | 2525175-90-8 | Details |
| CXCR4 antagonist 5 | C21H30N6 | 2304749-86-6 | Details |
| TNIK-IN-4 | C20H16FN3O3 | 2754266-04-9 | Details |
| Anticancer agent 57 | C20H21Cl2NO2 | 2408017-71-8 | Details |
| Antitumor agent-53 | C24H18FN3O | 2757145-67-6 | Details |
| RBM10-8 | C17H36NO5P | 2407372-42-1 | Details |
| ATR-IN-19 | C18H19N7OS | 2648989-61-9 | Details |
| ATG7-IN-3 | C11H16N6O5S2 | 2226229-76-9 | Details |
| TYK2-IN-11 | C18H17N5O3S | 2757009-40-6 | Details |
| DNA-PK-IN-2 | C20H23N5O3 | 2665720-22-7 | Details |
| SARS-CoV-2-IN-20 | C24H30N2O2 | 1260244-33-4 | Details |
| Plasma kallikrein-IN-3 | C20H23N5O2 | 1357950-47-0 | Details |
| Nampt-IN-7 | C20H21N5O3 | 1223378-42-4 | Details |
| Antibacterial agent 106 | C20H24N6S | 2459657-11-3 | Details |
| Z164597606 | C20H19N3O4 | 1050587-57-9 | Details |
| ATR-IN-15 | C19H22N8O | 2756665-52-6 | Details |
| EV-A71-IN-1 | C21H15N5S | 2413648-96-9 | Details |
| ATR-IN-16 | C19H25N7O | 2756589-62-3 | Details |
| 11β-HSD1-IN-6 | C21H19ClN4O | 1303515-33-4 | Details |
| S1P1 agonist 4 | C24H31NO3 | 1883345-11-6 | Details |
| LSD1-IN-14 | C21H24FN5 | 2698340-11-1 | Details |
| KDM5B-IN-3 | C19H25ClN4O2 | 1385101-10-9 | Details |
| DMX-129 | C19H17FN8 | 1623123-95-4 | Details |
| HBV-IN-21 | C17H17FN4OS2 | 2460957-52-0 | Details |
| c-ABL-IN-3 | C17H11F3N4O3 | 2626934-64-1 | Details |
| Tubulin polymerization-IN-13 | C20H21NO6 | 2426665-56-5 | Details |
| DHFR-IN-4 | C18H21N5O2S | 2820126-49-4 | Details |
| GLP-1R modulator C5 | C24H21NO3 | 421578-93-0 | Details |
| HPK1-IN-18 | C24H24N4 | 2403598-42-3 | Details |
| Neuraminidase-IN-5 | C19H11NO7 | 2473524-63-7 | Details |
| Antiparasitic agent-5 | C20H16ClN3O3 | 2494276-55-8 | Details |
| Anti-inflammatory agent 22 | C22H16O6 | 2721484-76-8 | Details |
| DPP-4 inhibitor 3 | C19H22N6O2 | 2402735-14-0 | Details |
| Anticancer agent 37 | C19H19N3O3S | 905783-28-0 | Details |
| DPP-4-IN-1 | C19H19ClN6 | 2215027-46-4 | Details |
| Influenza A virus-IN-4 | C19H28N4O4 | 2390067-58-8 | Details |
| AAK1-IN-4 | C20H28N4O3 | 1815612-79-3 | Details |
| Mt KARI-IN-4 | C13H8FN5O3S2 | 2413974-53-3 | Details |
| HDAC-IN-42 | C20H15NO7 | 2454024-18-9 | Details |
| ASK1-IN-3 | C18H18N8O2 | 2426705-19-1 | Details |
| PKC-IN-4 | C21H25N5S | 2636771-29-2 | Details |
| 5-HT2A receptor agonist-2 | C20H21ClN2O3 | 528525-37-3 | Details |
| Antifungal agent 32 | C25H28N2O | 1809167-48-3 | Details |
| Tyrosinase-IN-3 | C21H23NO5 | 2409081-40-7 | Details |
| Polyketide synthase 13-IN-2 | C22H21NO5 | 2219338-48-2 | Details |
| 3-(3-Phenoxybenzyl)amino-β-carboline | C24H19N3O | 1327080-54-5 | Details |
| S07-2010 | C19H21N3O3S | 1223194-71-5 | Details |
| EGFR-IN-52 | C19H18N4O3S | 454436-75-0 | Details |
| IMMH001 | C23H28N2O3 | 1418093-75-0 | Details |
| PPARγ agonist 3 | C24H23N3O | 2011801-48-0 | Details |
| Aldose reductase-IN-6 | C20H16N4O2S | 2470019-41-9 | Details |
| FGFR-IN-7 | C16H21ClF2N4O2 | 2488764-17-4 | Details |
| VPC-13789 | C21H16F3N3O | 2761146-51-2 | Details |
| Antileishmanial agent-9 | C23H26O4 | 2477608-91-4 | Details |
| Tubulin/HDAC-IN-1 | C21H18N4O3 | 2413587-26-3 | Details |
| Gü1303 | C20H22N4O3 | 1043922-53-7 | Details |
| Mt KARI-IN-2 | C14H11N5O4S2 | 2413974-52-2 | Details |
| 5-HT7 receptor ligand 1 | C21H23N7 | 2758571-64-9 | Details |
| VEGFR-2-IN-23 | C22H15N5O2 | 2411174-53-1 | Details |
| Anti-inflammatory agent 8 | C18H15N5OS2 | 1103920-19-9 | Details |
| CB1-IN-2 | C17H19Cl2N5O | 2527805-39-4 | Details |
| FAK-IN-8 | C15H9Cl2N3O2S | 1374959-91-7 | Details |
| TOPK-p38/JNK-IN-1 | C17H15F3N2O4 | 2745108-35-2 | Details |
| SK3 Channel-IN-1 | C25H49NO | 2396571-04-1 | Details |
| Falcipain-2/3-IN-2 | C21H23N3O4 | 946209-23-0 | Details |
| Anticancer agent 47 | C19H14N2O4S | 2461795-23-1 | Details |
| Trk-IN-20 | C22H18F2N4 | 2460924-63-2 | Details |
| TP0480066 | C18H14FN3O5 | 2245693-15-4 | Details |
| NPR-C activator 1 | C18H24N6O3 | 2768328-61-4 | Details |
| HIF-2α-IN-5 | C15H12F4O3S2 | 2388500-66-9 | Details |
| PKM2 activator 3 | C15H11ClF2N2O3S | 1346113-84-5 | Details |
| (S)-Cdc7-IN-18 | C19H21N5OS | 2562329-13-7 | Details |
| CXCR4 antagonist 9 | C21H27FN6 | 2304750-83-0 | Details |
| PPARγ agonist 7 | C20H30O6 | 2569295-93-6 | Details |
| ERK5-IN-4 | C16H11Cl2FN4O2 | 1888305-17-6 | Details |
| NHE3-IN-3 | C16H16Cl2N2O2S | 543734-50-5 | Details |
| hCAI/II-IN-4 | C15H15N3O5S2 | 2480284-01-1 | Details |
| NSC381467 | C20H16O7 | 1033006-96-0 | Details |
| Product Total： Product Page： | ||||
| 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 | ||||